Table 1.

Patient characteristics





Medical history


Patient
Sex
Age, y
Hemopathy
Neoplasia
Others
Immunosuppression
Cause of HPS
Evolution
1   F   48   No   No   No   CS   Parasite infection   Favorable  
2   M   15   No   No   No   No   Viral infection   Favorable  
3   F   86   No   Colon   Dermatomyositis   CS   Bacterial infection   Death  
4   M   42   No   No   No   No   Viral infection   Favorable  
5   F   55   No   No   Still disease   CS and CP   Bacterial infection   Favorable  
6   M   39   No   No   No   Chronic ethylic intoxication   Infection (K pneumoniae)   Favorable  
7   M   59   No   No   No   No   Viral infection   Favorable  
8   M   81   No   No   No   No   Viral infection (HSV)   Favorable  
9   F   83   No   No   No   No   Non-Hodgkin lymphoma   Death  
10   M   83   No   Prostate   No   No   Metastatic neoplasia   Death  
11   M   58   No   No   No   Chronic ethylic intoxication   Viral infection   Favorable  
12   F   77   No   No   No   No   Non-Hodgkin lymphoma   Death  
13   M   62   No   No   No   No   Viral infection (VZV)   Favorable  
14   M   62   No   No   No   No   Non-Hodgkin lymphoma   Death  
15   M   50   CLL   No   No   No   Bacterial infection   Favorable  
16   F   37   No   No   AIHA   No   Viral infection   Favorable  
17   F   62   No   No   No   No   Viral infection   Favorable  
18   M   61   No   No   No   No   Nonidentified   Favorable  
18 bis     No   No   No   No   Nonidentified   Favorable  
19   F   44   No   No   Chronic hepatitis C   No   Nonidentified   Death  
20
 
F
 
41
 
No
 
No
 
SLE/RA/APS
 
CS and splenectomy
 
Bacterial infection
 
Favorable
 




Medical history


Patient
Sex
Age, y
Hemopathy
Neoplasia
Others
Immunosuppression
Cause of HPS
Evolution
1   F   48   No   No   No   CS   Parasite infection   Favorable  
2   M   15   No   No   No   No   Viral infection   Favorable  
3   F   86   No   Colon   Dermatomyositis   CS   Bacterial infection   Death  
4   M   42   No   No   No   No   Viral infection   Favorable  
5   F   55   No   No   Still disease   CS and CP   Bacterial infection   Favorable  
6   M   39   No   No   No   Chronic ethylic intoxication   Infection (K pneumoniae)   Favorable  
7   M   59   No   No   No   No   Viral infection   Favorable  
8   M   81   No   No   No   No   Viral infection (HSV)   Favorable  
9   F   83   No   No   No   No   Non-Hodgkin lymphoma   Death  
10   M   83   No   Prostate   No   No   Metastatic neoplasia   Death  
11   M   58   No   No   No   Chronic ethylic intoxication   Viral infection   Favorable  
12   F   77   No   No   No   No   Non-Hodgkin lymphoma   Death  
13   M   62   No   No   No   No   Viral infection (VZV)   Favorable  
14   M   62   No   No   No   No   Non-Hodgkin lymphoma   Death  
15   M   50   CLL   No   No   No   Bacterial infection   Favorable  
16   F   37   No   No   AIHA   No   Viral infection   Favorable  
17   F   62   No   No   No   No   Viral infection   Favorable  
18   M   61   No   No   No   No   Nonidentified   Favorable  
18 bis     No   No   No   No   Nonidentified   Favorable  
19   F   44   No   No   Chronic hepatitis C   No   Nonidentified   Death  
20
 
F
 
41
 
No
 
No
 
SLE/RA/APS
 
CS and splenectomy
 
Bacterial infection
 
Favorable
 

F indicates female; CS, corticosteroids; M, male; CP, cyclophosphamide; K pneumoniae, Klebsiella pneumoniae; HSV, herpes simplex virus; VZV, varicella zoster virus; CLL, chronic lymphoid leukemia; AIHA, autoimmune hemolytic anemia; SLE, systemic lupus erythematosus; RA, rheumatism arthritis; and APS, antiphospholipid syndrome.

or Create an Account

Close Modal
Close Modal